Investor Alert

Company Close Updates Archives | Email alerts

Nov. 20, 2020, 5:01 p.m. EST

Corbus Pharmaceuticals Holdings Inc. stock remains steady Friday, still outperforms market

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP were unchanged Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.42% to 11,854.97 and Dow Jones Industrial Average DJIA falling 0.75% to 29,263.48. Corbus Pharmaceuticals Holdings Inc. closed $8.57 below its 52-week high ($9.78), which the company reached on August 31st.

The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Fate Therapeutics Inc. FATE rose 5.91% to $52.65, Vanda Pharmaceuticals Inc. VNDA fell 0.88% to $12.36, and Viking Therapeutics Inc. VKTX rose 1.61% to $6.31. Trading volume (2.4 M) remained 2.6 million below its 50-day average volume of 5.0 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.